| Dr Loren A Olson, MD, DLFAPA | |
|
4908 Franklin Ave, Des Moines, IA 50310-1901 | |
| (515) 280-4930 | |
| (515) 309-0686 |
| Full Name | Dr Loren A Olson |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 56 Years |
| Location | 4908 Franklin Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184613101 | NPI | - | NPPES |
| 102269 | Other | IA | VALUE OPTIONS |
| 1184613101 | Other | IA | WELLMARK BCBS |
| 1184613101 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 21941 (Iowa) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2021003893 (Missouri) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mosaic Medical Center - Maryville | 3678813896 | 89 |
News Archive
In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.
The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.
Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.
Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced the completion of a $25 million Series C round of growth capital financing. New investor ProQuest Investments led the round, joined by all current investors: Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.
BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.
› Verified 4 days ago
| Entity Name | Mosaic Medical Center - Maryville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184189797 PECOS PAC ID: 3678813896 Enrollment ID: O20190405001537 |
News Archive
In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.
The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.
Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.
Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced the completion of a $25 million Series C round of growth capital financing. New investor ProQuest Investments led the round, joined by all current investors: Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.
BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Loren A Olson, MD, DLFAPA 2213 Grand Ave, Des Moines, IA 50312-5305 Ph: (515) 237-3974 | Dr Loren A Olson, MD, DLFAPA 4908 Franklin Ave, Des Moines, IA 50310-1901 Ph: (515) 280-4930 |
News Archive
In breast cancer patients with metastatic disease, bone is the most common site of metastasis and the most common site of first distant relapse, with roughly half (48%) of breast cancer patients developing bone metastases after treatment.
The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.
Patients in early clinical trials of new-style targeted cancer therapies appear to have a much lower risk of the most serious side-effects than with traditional chemotherapy, according to a new analysis.
Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced the completion of a $25 million Series C round of growth capital financing. New investor ProQuest Investments led the round, joined by all current investors: Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.
BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.
› Verified 4 days ago
Sasha Farshid Khosravi, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St, Suite 3310, Des Moines, IA 50314 Phone: 515-643-6290 Fax: 515-643-6291 | |
Kaitlin A Scarborough, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2682 Fax: 515-643-5802 | |
Kelli Green, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1801 Hickman Rd, Broadlawns Medical Center, Des Moines, IA 50314 Phone: 515-282-2319 Fax: 515-282-3234 | |
Mr. Brahmananda P Makkapati, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-2200 | |
Mohammad A Hussain, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2682 Fax: 515-643-5802 | |
Austin Zeng, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2630 Fax: 515-643-5802 | |
Teresa Marie Dolphin-shaw, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1801 Hickman Rd, Des Moines, IA 50314 Phone: 515-282-5695 |